Home » Newsletters » BioWorld Science

BioWorld Science

April 28, 2000

View Archived Issues

Wilex updates product pipeline, focusing on forward integration

Centaur's treatment for AIDS dementia making steady progress in phase II

Synergistic anti-HBV combinations under study at Glaxo Wellcome

Novel growth factor from the GDNF family discovered by U.S. academics

PEG-Intron at least as effective and safe as Intron A in phase III HCV trial

AastromRepliCell System offers hope for CML patients

Altropane shows high accuracy, sensitivity and specificity as diagnostic for early PD

Abbott's extended-release Biaxin XL now available in U.S.

Integrin antagonists disclosed by BioChem Pharma for inhibiting angiogenesis and tumor growth

Japanese lab presents novel agents for AD and other neurodegenerative diseases

New antimigraine agents in early development at NPS with selectivity for 5-HT1D receptor

SCRAS presents another group of dual NOS inhibitors/antioxidants

Several patents issued to Pfizer covering CETP inhibitors and their use

Merck's new CGRP ligands particularly useful in migraine Rx

Global CORAL study will evaluate oral Copaxone in relapsing-remitting MS

SB researchers publish synthesis of new PDE4 inhibitor

Licensing opportunity from NIH: HIV-1 integrase inhibitors

Microbial metabolite Sch-351448 acts as a selective LDL receptor promoter activator

Licensing opportunity from NIH: MAb for the treatment, diagnosis of prostate cancer

New Canadian venture formed for the development of heart disease and stroke therapies

Licensing opportunity from NIH: antibodies and immunotoxins for treating, diagnosing cancer

ADL-2-1294 licensed to Santen for ophthalmic indications

Dapsone topical gel progresses through the pipeline for acne and itch

FDA grants expedited review to first PCR-based tests for HCV

Structure and cardioprotective effects of RC-552 reported at Experimental Biology 2000

Antisense oligodeoxynucleotides with potential in hypertension and myocardial hypertrophy

ITB Therapy copromotion alliance expanded by Cephalon and Medtronic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...